Russell Investments Group
RCKT icon

Russell Investments Group’s Rocket Pharmaceuticals RCKT Stock Holding History

Russell Investments Group’s Portfolio RCKT Stock Details RCKT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$516K Buy
150,933
+96,330
+176% +$320K ﹤0.01% 2766
2026
Q1 		$195K Buy
54,603
+44,374
+434% +$176K ﹤0.01% 2857
2025
Q4 		$35.9K Sell
10,229
-3,843
-27% -$13.2K ﹤0.01% 3416
2025
Q3 		$45.9K Buy
14,072
+13,594
+2,844% +$42.8K ﹤0.01% 3327
2025
Q2 		$1.17K Sell
478
-24,180
-98% -$122K ﹤0.01% 3654
2025
Q1 		$164K Sell
24,658
-767,219
-97% -$7.58M ﹤0.01% 2644
2024
Q4 		$9.95M Sell
791,877
-20,433
-3% -$308K 0.01% 820
2024
Q3 		$15M Buy
812,310
+134,566
+20% +$2.76M 0.02% 683
2024
Q2 		$14.6M Buy
677,744
+1,975
+0.3% +$45.4K 0.02% 644
2024
Q1 		$18.2M Buy
675,769
+26,823
+4% +$762K 0.03% 584
2023
Q4 		$19.4M Sell
648,946
-79,463
-11% -$1.75M 0.03% 526
2023
Q3 		$14.9M Buy
728,409
+143,695
+25% +$2.61M 0.03% 578
2023
Q2 		$11.6M Buy
584,714
+79,192
+16% +$1.6M 0.02% 706
2023
Q1 		$8.66M Buy
505,522
+125,476
+33% +$2.46M 0.02% 836
2022
Q4 		$7.44M Buy
380,046
+199,945
+111% +$3.68M 0.02% 893
2022
Q3 		$2.87M Buy
180,101
+6,785
+4% +$106K 0.01% 1350
2022
Q2 		$2.38M Buy
+173,316
New +$2.07M ﹤0.01% 1500

Other funds holding RCKT

RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
NM
Newtyn Management New York $801M AUM 23.14% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $11.3B AUM 76.6% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Russell Investments Group's RCKT Position: Q2 2026 in Review

Russell Investments Group increased its Rocket Pharmaceuticals (RCKT) stake by 176% in Q2 2026, buying an estimated $320K and bringing the position to 150,933 shares worth $516K. The position accounts for ﹤0.01% of the portfolio, ranked #2766.

Russell Investments Group first reported a position in RCKT in Q2 2022 and has held it in 17 quarters since. The position peaked at $19.4M in Q4 2023. 180 funds tracked by Wall St. Rank hold RCKT as of Q2 2026.

  • Russell Investments Group held 150,933 shares of Rocket Pharmaceuticals worth $516K as of Q2 2026.
  • Russell Investments Group bought 96,330 Rocket Pharmaceuticals shares in Q2 2026, an estimated $320K.
  • Rocket Pharmaceuticals made up ﹤0.01% of Russell Investments Group's portfolio in Q2 2026, its #2766 holding.
  • Russell Investments Group first reported a position in Rocket Pharmaceuticals in Q2 2022 and has held it in 17 quarters since.
  • Russell Investments Group's Rocket Pharmaceuticals position peaked at $19.4M in Q4 2023.
  • 180 funds tracked by Wall St. Rank held Rocket Pharmaceuticals as of Q2 2026.

Based on Russell Investments Group's 13F filing for Q2 2026, filed 6 Aug 2026.